Our Publications

March 02 - 2026

Pathophysiology of fetal growth: IGF system and parental imprinting

https://en.crsa.fr/team-irene-netchine.html

Learn more

February 11 - 2026

Women and Girls in Science Day

https://en.crsa.fr/women-and-girls-in-science-day.html

Learn more

February 10 - 2026

Biliary and Fatty Liver Diseases

https://en.crsa.fr/team-jeremie-gautheron.html

Learn more

February 02 - 2026

CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis

Cell Death Dis. 2026 Feb 11;17(1):219

Learn more

February 01 - 2026

Hematopoietic and Leukemic Development

https://en.crsa.fr/team-francois-delhommeau.html

Learn more

January 19 - 2026

Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes

Gastroenterology. 2026 Jan 19:S0016-5085(25)06108-6.

Learn more

January 01 - 2026

Immune Modulation by Personalized vs Standard Prehabilitation Before Major SurgeryA Randomized Clinical Trial

JAMA Surg. 2026 Jan 1;161(1):20-30. Importance: Prehabilitation programs are increasingly recognized for their potential to improve surgical outcomes. However, their efficacy...

Learn more

December 18 - 2025

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis

Sci Adv. 2025 Dec 19;11(51):eadz7907 Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no effective curative therapies. Necroptosis, a regulated...

Learn more

November 22 - 2025

ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators

Sci Rep. 2025 Nov 22. The hepato-canalicular adenosine triphosphate (ATP)-binding cassette transporter ABCB4/MDR3 is responsible of the secretion of phosphatidylcholine (PC) into...

Learn more

November 07 - 2025

Saccharomyces boulardii CNCM I-745 mitigates antibiotic-induced gut microbiome functional alterations independently of the host

Gut Microbes. 2025 Dec 31;17(1):2575924 ABSTRACT: The probiotic Saccharomyces boulardii CNCM I-745 (Sb) is widely prescribed to alleviate antibiotic-induced diarrhea, yet its...

Learn more

Latest publications

Publication of various scientific studies

Pathophysiology of fetal growth: IGF system and parental imprinting

Women and Girls in Science Day

Biliary and Fatty Liver Diseases

CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis

Hematopoietic and Leukemic Development

Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes

Immune Modulation by Personalized vs Standard Prehabilitation Before Major SurgeryA Randomized Clinical Trial

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis

ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators

Saccharomyces boulardii CNCM I-745 mitigates antibiotic-induced gut microbiome functional alterations independently of the host